JPH08145997A - Composition for method for measuring enzyme immunity and kit for measuring enzyme immunity - Google Patents
Composition for method for measuring enzyme immunity and kit for measuring enzyme immunityInfo
- Publication number
- JPH08145997A JPH08145997A JP28529794A JP28529794A JPH08145997A JP H08145997 A JPH08145997 A JP H08145997A JP 28529794 A JP28529794 A JP 28529794A JP 28529794 A JP28529794 A JP 28529794A JP H08145997 A JPH08145997 A JP H08145997A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- composition
- tetraalkylbenzidine
- enzyme immunoassay
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 36
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title abstract description 13
- 230000036039 immunity Effects 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 41
- 150000003839 salts Chemical class 0.000 claims abstract description 17
- 239000007800 oxidant agent Substances 0.000 claims abstract description 11
- 238000003018 immunoassay Methods 0.000 claims description 31
- 238000006243 chemical reaction Methods 0.000 claims description 11
- -1 nitrogen-containing heterocyclic compound Chemical class 0.000 claims description 10
- 150000003462 sulfoxides Chemical class 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 239000012295 chemical reaction liquid Substances 0.000 claims 2
- 108040007629 peroxidase activity proteins Proteins 0.000 abstract description 16
- 238000011088 calibration curve Methods 0.000 abstract description 13
- 239000000427 antigen Substances 0.000 abstract description 8
- 102000036639 antigens Human genes 0.000 abstract description 8
- 108091007433 antigens Proteins 0.000 abstract description 8
- 238000005259 measurement Methods 0.000 abstract description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 6
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- 102000003992 Peroxidases Human genes 0.000 abstract 1
- 229940125904 compound 1 Drugs 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 28
- 229940088598 enzyme Drugs 0.000 description 26
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- 102000013415 peroxidase activity proteins Human genes 0.000 description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 14
- 239000000126 substance Substances 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- NNWUEBIEOFQMSS-UHFFFAOYSA-N 2-Methylpiperidine Chemical compound CC1CCCCN1 NNWUEBIEOFQMSS-UHFFFAOYSA-N 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical class C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102000030902 Galactosyltransferase Human genes 0.000 description 2
- 108060003306 Galactosyltransferase Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 229960002303 citric acid monohydrate Drugs 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- LCEDQNDDFOCWGG-UHFFFAOYSA-N morpholine-4-carbaldehyde Chemical compound O=CN1CCOCC1 LCEDQNDDFOCWGG-UHFFFAOYSA-N 0.000 description 2
- 230000007886 mutagenicity Effects 0.000 description 2
- 231100000299 mutagenicity Toxicity 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- WDQFELCEOPFLCZ-UHFFFAOYSA-N 1-(2-hydroxyethyl)pyrrolidin-2-one Chemical compound OCCN1CCCC1=O WDQFELCEOPFLCZ-UHFFFAOYSA-N 0.000 description 1
- CVDGNRZPDAXOQO-UHFFFAOYSA-N 1-(3-hydroxypropyl)pyrrolidin-2-one Chemical compound OCCCN1CCCC1=O CVDGNRZPDAXOQO-UHFFFAOYSA-N 0.000 description 1
- XTBWGPZBRPCECM-UHFFFAOYSA-N 1-(5-hydroxypentyl)pyrrolidin-2-one Chemical compound OCCCCCN1CCCC1=O XTBWGPZBRPCECM-UHFFFAOYSA-N 0.000 description 1
- KAXXYLDEYGTGHM-UHFFFAOYSA-N 1-(8-hydroxyoctyl)pyrrolidin-2-one Chemical compound OCCCCCCCCN1CCCC1=O KAXXYLDEYGTGHM-UHFFFAOYSA-N 0.000 description 1
- PJEXUIKBGBSHBS-UHFFFAOYSA-N 1-(hydroxymethyl)pyrrolidin-2-one Chemical compound OCN1CCCC1=O PJEXUIKBGBSHBS-UHFFFAOYSA-N 0.000 description 1
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 description 1
- BNXZHVUCNYMNOS-UHFFFAOYSA-N 1-butylpyrrolidin-2-one Chemical compound CCCCN1CCCC1=O BNXZHVUCNYMNOS-UHFFFAOYSA-N 0.000 description 1
- NJPQAIBZIHNJDO-UHFFFAOYSA-N 1-dodecylpyrrolidin-2-one Chemical compound CCCCCCCCCCCCN1CCCC1=O NJPQAIBZIHNJDO-UHFFFAOYSA-N 0.000 description 1
- HUUPVABNAQUEJW-UHFFFAOYSA-N 1-methylpiperidin-4-one Chemical compound CN1CCC(=O)CC1 HUUPVABNAQUEJW-UHFFFAOYSA-N 0.000 description 1
- DCALJVULAGICIX-UHFFFAOYSA-N 1-propylpyrrolidin-2-one Chemical compound CCCN1CCCC1=O DCALJVULAGICIX-UHFFFAOYSA-N 0.000 description 1
- BXGYBSJAZFGIPX-UHFFFAOYSA-N 2-pyridin-2-ylethanol Chemical compound OCCC1=CC=CC=N1 BXGYBSJAZFGIPX-UHFFFAOYSA-N 0.000 description 1
- XOMYTIUVNSWEAI-UHFFFAOYSA-N 3-(2-oxopyrrolidin-1-yl)propanoic acid Chemical compound OC(=O)CCN1CCCC1=O XOMYTIUVNSWEAI-UHFFFAOYSA-N 0.000 description 1
- MVQVNTPHUGQQHK-UHFFFAOYSA-N 3-pyridinemethanol Chemical compound OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 description 1
- WRDMYTORSDPYMO-UHFFFAOYSA-N 4-(2-oxopyrrolidin-1-yl)butanoic acid Chemical compound OC(=O)CCCN1CCCC1=O WRDMYTORSDPYMO-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- ZJAFQAPHWPSKRZ-UHFFFAOYSA-N 4-nitrobenzenecarboperoxoic acid Chemical compound OOC(=O)C1=CC=C([N+]([O-])=O)C=C1 ZJAFQAPHWPSKRZ-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- 108060006006 Cytochrome-c peroxidase Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102100038609 Lactoperoxidase Human genes 0.000 description 1
- 108090000235 Myeloperoxidases Proteins 0.000 description 1
- 102000003896 Myeloperoxidases Human genes 0.000 description 1
- WPPOGHDFAVQKLN-UHFFFAOYSA-N N-Octyl-2-pyrrolidone Chemical compound CCCCCCCCN1CCCC1=O WPPOGHDFAVQKLN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 238000012925 biological evaluation Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- WRKRMDNAUJERQT-UHFFFAOYSA-N cumene hydroxyperoxide Chemical compound OOOO.CC(C)C1=CC=CC=C1 WRKRMDNAUJERQT-UHFFFAOYSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- SHNUBALDGXWUJI-UHFFFAOYSA-N pyridin-2-ylmethanol Chemical compound OCC1=CC=CC=N1 SHNUBALDGXWUJI-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、酵素免疫測定法、生化
学的測定法などの分野において利用されるペルオキシダ
ーゼ様物質及び酸化性物質の測定用組成物及びそれらの
物質を測定するためのキットに関する。さらに詳しく
は、この組成物又はキットの医学的診断もしくは生物学
的評価への利用に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition for measuring peroxidase-like substances and oxidative substances, which is used in the fields of enzyme immunoassay, biochemical assay and the like, and a kit for measuring those substances. Regarding More specifically, it relates to the use of this composition or kit for medical diagnosis or biological evaluation.
【0002】[0002]
【従来の技術】ペルオキシダーゼ様物質または酸化性物
質を測定するために用いられるベンジジン系の化合物
は、変異原性が低いあるいは全く持たないものが多く、
しかも感度が良いことで知られている。そのため、ベン
ジジン系の化合物、中でもテトラアルキルベンジジンに
関しては数多くの検討及び、改良がなされている。従
来、テトラアルキルベンジジンを使用する際の問題点と
して挙げられてきたものには、テトラアルキルベンジジ
ンの溶解性の低さ、長期保存するときの保存安定性、使
用時にいかに簡便に発色液を調製するか、などがある。
そして、特開昭62-134100号、特開昭63-199270号、特開
平1-104196号、特公平6-38757号、特開平6-165696号な
どに開示されている方法によってこれらの問題点は、解
決されてきている。2. Description of the Related Art Many benzidine compounds used for measuring peroxidase-like substances or oxidative substances have low mutagenicity or have no mutagenicity,
Moreover, it is known for its good sensitivity. Therefore, many studies and improvements have been made on benzidine compounds, especially tetraalkylbenzidine. Conventionally, problems that have been mentioned as problems when using tetraalkylbenzidine include low solubility of tetraalkylbenzidine, storage stability during long-term storage, and how easily a color developing solution is prepared at the time of use. Or, etc.
These problems are solved by the methods disclosed in JP-A-62-134100, JP-A-63-199270, JP-A-1-104196, JP-B-6-38757, JP-A-6-165696 and the like. Has been resolved.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、発明者
はこれら公知の方法を検討した結果、現在全く問題にさ
れていない驚くべき事実を発見した。その問題とは、現
在知られているテトラアルキルベンジジンを用いた方法
では、特にEIA、ELISAなどペルオキシダーゼ標識抗体を
用いる測定系において検量線が直線にならないという現
象である。この現象は、遊離のペルオキシダーゼを用い
た系では観察されず、ペルオキシダーゼ標識抗体を用い
た反応系のみで観察されている。また、ペルオキシダー
ゼ標識抗体を用いた測定系であってもo-フェニレンジア
ミンなどベンジジン系ではない発色剤を用いた場合では
検量線は、ほぼ直線となる。このことから、この問題が
ベンジジン系の発色剤に特有のものであり、しかもペル
オキシダーゼ標識抗体を用いた反応系のみで観察されて
いる。However, as a result of examining these known methods, the inventor discovered a surprising fact that has not been a problem at present. The problem is a phenomenon that the calibration curve is not linear in the currently known method using tetraalkylbenzidine, especially in a measurement system using a peroxidase-labeled antibody such as EIA and ELISA. This phenomenon is not observed in the system using free peroxidase, but only in the reaction system using the peroxidase-labeled antibody. Further, even in a measurement system using a peroxidase-labeled antibody, the calibration curve becomes almost linear when a non-benzidine-based coloring agent such as o-phenylenediamine is used. From this, this problem is peculiar to the benzidine-based color-developing agent and has been observed only in the reaction system using the peroxidase-labeled antibody.
【0004】上記に示した公知の方法の検討により、ジ
メチルホルムアミド(DMF)、メタノールなどの有機溶媒
を用いた場合においても、また、酸性度の高い溶液に溶
解する方法を用いた場合においても、検量線が直線にな
らないという現象は再現的に観察されることが明らかに
なった。According to the examination of the publicly known method shown above, even when an organic solvent such as dimethylformamide (DMF) or methanol is used, or when a method of dissolving in a highly acidic solution is used, It became clear that the phenomenon that the calibration curve was not linear was observed reproducibly.
【0005】この現象により結果の再現性及び測定の精
度が低下することは明らかであり、得られたデータの信
頼性にもかかわる。特に、利用対象となる分野が医療分
野であるだけに大きな誤差は、誤診にもつながりかねな
い危険性をはらんでいる。にもかかわらず、この現象は
これまでに報告例もなく、問題提起されていないなど、
注目されていなかったと考えられる。当然のことなが
ら、これまでに報告されたいずれの方法においてもこの
問題を解決するには至っていない。It is clear that this phenomenon reduces the reproducibility of the results and the accuracy of the measurement, and also affects the reliability of the data obtained. Particularly, since the field to be used is a medical field, a large error entails a risk that it may lead to misdiagnosis. Nevertheless, this phenomenon has not been reported so far, no problem has been raised, etc.
It is believed that it did not attract attention. Naturally, none of the previously reported methods have solved this problem.
【0006】本発明の目的は、調製が容易で発色感度、
検量線の直線性に優れた酵素免疫測定法のための組成物
を提供すること、そして、この組成物を用いることによ
る再現性の高い測定系を提供することにある。更に、本
発明はペルオキシダーゼを結合した抗体もしくは抗原分
子を用いた固相酵素免疫測定法において、テトラアルキ
ルベンジジンまたはその塩を用いた場合、再現性の向上
を目的とする。The object of the present invention is to make the preparation easy and the color development sensitivity,
It is intended to provide a composition for an enzyme immunoassay having excellent linearity of a calibration curve, and to provide a highly reproducible measurement system by using this composition. Furthermore, the present invention aims to improve reproducibility when a tetraalkylbenzidine or a salt thereof is used in a solid-phase enzyme immunoassay using an antibody or antigen molecule bound with peroxidase.
【0007】[0007]
【課題を解決するための手段】本発明の上記目的は下記
の構成により達成される。The above objects of the present invention can be achieved by the following constitutions.
【0008】1) テトラアルキルベンジジンまたはそ
の塩と酸化性物質を含有し、かつ、ジアルキルスルフォ
キシド及び含窒素ヘテロ6員環化合物から選ばれる少な
くとも1種の化合物を30〜60%(v/v)の割合で含有する
ことを特徴とする酵素免疫測定法用組成物。1) 30 to 60% (v / v) of at least one compound containing tetraalkylbenzidine or a salt thereof and an oxidizing substance and selected from dialkyl sulfoxide and a nitrogen-containing hetero 6-membered ring compound. ) The composition for enzyme immunoassay, characterized in that the composition is contained.
【0009】2) テトラアルキルベンジジンまたはそ
の塩と酸化性物質を含有し、かつ、下記一般式〔I〕で
表される化合物の少なくとも2種を30〜60%(v/v)の割
合で含有することを特徴とする酵素免疫測定法用組成
物。2) Containing tetraalkylbenzidine or a salt thereof and an oxidizing substance, and containing at least two compounds represented by the following general formula [I] in a proportion of 30 to 60% (v / v). A composition for enzyme immunoassay characterized by comprising:
【0010】[0010]
【化2】 Embedded image
【0011】式中、Rは置換又は非置換のアルキル基を
表す。In the formula, R represents a substituted or unsubstituted alkyl group.
【0012】3) テトラアルキルベンジジンまたはそ
の塩と酸化性物質を含有し、かつ、ジアルキルスルフォ
キシド及び含窒素ヘテロ環化合物から選ばれる少なくと
も1種の化合物並びに上記一般式〔I〕で表される化合
物から選ばれる少なくとも1種の化合物を30〜60%(v/
v)の割合で含有することを特徴とする酵素免疫測定法用
組成物。3) At least one compound containing tetraalkylbenzidine or a salt thereof and an oxidizing substance and selected from a dialkyl sulfoxide and a nitrogen-containing heterocyclic compound and represented by the above general formula [I]. 30-60% (v /
A composition for enzyme immunoassay, characterized in that it is contained in the ratio of v).
【0013】4) テトラアルキルベンジジンまたはそ
の塩を含有し、かつ、ジアルキルスルフォキシド及び含
窒素ヘテロ環化合物から選ばれる少なくとも1種の化合
物を反応液中に30〜60%(v/v)の割合で含有することを
特徴とする酵素免疫測定用キット。4) 30 to 60% (v / v) of at least one compound containing tetraalkylbenzidine or a salt thereof and selected from dialkyl sulfoxide and nitrogen-containing heterocyclic compound A kit for enzyme immunoassay, characterized in that it is contained in a ratio.
【0014】5) テトラアルキルベンジジンまたはそ
の塩を含有し、かつ、上記一般式〔I〕で表される化合
物から選ばれる少なくとも2種の化合物を反応液中に30
〜60%(v/v)の割合で含有することを特徴とする酵素免
疫測定用キット。5) At least two compounds containing tetraalkylbenzidine or a salt thereof and selected from the compounds represented by the above general formula [I] are added to the reaction solution in an amount of 30
An enzyme immunoassay kit, characterized in that the kit is contained at a ratio of -60% (v / v).
【0015】6) テトラアルキルベンジジンまたはそ
の塩を含有し、かつ、ジアルキルスルフォキシド及び含
窒素ヘテロ環化合物から選ばれる少なくとも1種の化合
物並びに上記一般式〔I〕で表される化合物から選ばれ
る少なくとも1種の化合物を反応液中に30〜60%(v/v)
の割合で含有することを特徴とする酵素免疫測定用キッ
ト。6) It is selected from at least one compound containing tetraalkylbenzidine or a salt thereof and selected from a dialkyl sulfoxide and a nitrogen-containing heterocyclic compound, and a compound represented by the above general formula [I]. 30-60% (v / v) of at least one compound in the reaction mixture
A kit for enzyme immunoassay, characterized in that it is contained at a ratio of.
【0016】7) テトラアルキルベンジジンが3,3′,
5,5′-テトラメチルベンジジンであることを特徴とする
前記1、2、3、4、5又は6記載の酵素免疫測定法用
組成物色原体又は酵素免疫測定用キット。7) The tetraalkylbenzidine is 3,3 ',
The composition chromogen for enzyme immunoassay or the kit for enzyme immunoassay according to 1, 2, 3, 4, 5 or 6, which is 5,5′-tetramethylbenzidine.
【0017】本発明において、ジアルキルスルフォキシ
ド又は含窒素ヘテロ環化合物(以後化合物群1とする)
に属する化合物としては、例えば、ジメチルスルフォキ
シド、ピペリジン、N-メチルピペリジン、2-メチルピペ
リジン、1-メチル-4-ピペリジノン、2-(2-ピリジル)エ
タノール、2-ピリジルメタノール、3-ピリジルメタノー
ル、モルホリン、N-ホルミルモルホリン等が挙げられ
る。In the present invention, a dialkyl sulfoxide or a nitrogen-containing heterocyclic compound (hereinafter referred to as compound group 1)
The compounds belonging to, for example, dimethylsulfoxide, piperidine, N-methylpiperidine, 2-methylpiperidine, 1-methyl-4-piperidinone, 2- (2-pyridyl) ethanol, 2-pyridylmethanol, 3-pyridyl Methanol, morpholine, N-formylmorpholine and the like can be mentioned.
【0018】発明者は、化合物群1から選択される化合
物を測定法用組成物中に高濃度に含有させることによっ
て、驚くべきことに検量線の直線性が大幅に改善される
ことを見いだした。既に知られている方法では、測定法
用組成物は、添加剤を5〜30%含有し、添加剤の濃度
はなるべく低く抑えるということが常識であった。しか
しながら、発明者の検討の結果、化合物群1より選択さ
れる化合物を30%以上含有させることで検量線の直線
性が改善される傾向が得られ、特に、35%以上の高濃度
で含有させた場合、極めて良好な直線性が得られること
が判明したのである。加えて、60%よりも混合率を上げ
ると、感度の低下が観察されることから、好ましくは35
〜60%の範囲で用いるのが効果的である。また、化合物
群1より選択される化合物は複数選択することも可能で
ある。この場合、測定法用組成物中に占める化合物の総
量の割合が35〜60%であれば2種ないし3種を組み合わ
せて使用することも可能である。そして、この発色液を
用いることにより、ペルオキシダーゼにより標識化され
た抗体または抗原を用いた酵素免疫測定法の系における
検量線の直線性が大幅に改善され、問題を解決するに至
った。The inventor has found that, by containing a compound selected from the compound group 1 at a high concentration in the composition for assay, the linearity of the calibration curve is remarkably improved. . In the already known methods, it was common knowledge that the measuring composition contains 5 to 30% of the additive and the concentration of the additive is kept as low as possible. However, as a result of the inventor's study, it was found that the linearity of the calibration curve tends to be improved by containing 30% or more of the compound selected from the compound group 1, and in particular, it is contained at a high concentration of 35% or more. It has been found that extremely good linearity can be obtained. In addition, if the mixing ratio is increased above 60%, a decrease in sensitivity is observed.
It is effective to use in the range of up to 60%. Further, it is possible to select a plurality of compounds selected from the compound group 1. In this case, it is also possible to use two or three types in combination as long as the total amount of the compounds in the composition for measurement is 35 to 60%. Then, by using this color-developing solution, the linearity of the calibration curve in the enzyme immunoassay system using the antibody or antigen labeled with peroxidase was significantly improved, and the problem was solved.
【0019】本発明の一般式〔I〕で表される化合物
は、例えば、N-メチル-2-ピロリジノン、N-エチル-2-ピ
ロリジノン、N-プロピル-2-ピロリジノン、N-ブチル-2-
ピロリジノン、N-オクチル-2-ピロリジノン、N-ドデシ
ル-2-ピロリジノン、N-ヒドロキシメチル-2-ピロリジノ
ン、N-(2-ヒドロキシエチル)-2-ピロリジノン、N-(3-ヒ
ドロキシプロピル)-2-ピロリジノン、N-(5-ヒドロキシ
ペンチル)-2-ピロリジノン、N-(8-ヒドロキシオクチル)
-2-ピロリジノン、2-ピロリジノン-1-酢酸、N-(2-カル
ボキシエチル)-2-ピロリジノン、N-(3-カルボキシプロ
ピル)-2-ピロリジノン等が挙げられる。The compound represented by the general formula [I] of the present invention is, for example, N-methyl-2-pyrrolidinone, N-ethyl-2-pyrrolidinone, N-propyl-2-pyrrolidinone or N-butyl-2-
Pyrrolidinone, N-octyl-2-pyrrolidinone, N-dodecyl-2-pyrrolidinone, N-hydroxymethyl-2-pyrrolidinone, N- (2-hydroxyethyl) -2-pyrrolidinone, N- (3-hydroxypropyl) -2 -Pyrrolidinone, N- (5-hydroxypentyl) -2-pyrrolidinone, N- (8-hydroxyoctyl)
-2-pyrrolidinone, 2-pyrrolidinone-1-acetic acid, N- (2-carboxyethyl) -2-pyrrolidinone, N- (3-carboxypropyl) -2-pyrrolidinone and the like can be mentioned.
【0020】本発明でいうペルオキシダーゼを結合した
抗体もしくは抗原分子を用いた酵素免疫測定法とは、医
学書院より1982年に初版が発行された「酵素免疫測定
法」(石川榮治らの編集)の30〜49ページ及び、東京化学
同人より1989年に初版が発行された「エンザイムイムノ
アッセイ」(P.TIJSSEN著、監訳石川榮治)の8〜19ペー
ジに記載されているような酵素免疫測定法であって、ペ
ルオキシダーゼ標識抗体または抗原を用い、ペルオキシ
ダーゼ活性量を酸化性物質及び発色剤で構成される発色
液を用いて測定する方法なら、どの様なものでも適合で
きる。The enzyme immunoassay method using an antibody or antigen molecule bound to peroxidase in the present invention refers to the "enzyme immunoassay method" (edited by Eiji Ishikawa et al.), Which was first published in 1982 by the Medical Shoin. The enzyme immunoassay method is as described on pages 30-49 and pages 8-19 of "Enzyme Immunoassay" (P.TIJSSEN, Eiji Ishikawa) published in 1989 by Tokyo Kagaku Dojin. Then, any method can be applied as long as it is a method of measuring the amount of peroxidase activity using a peroxidase-labeled antibody or antigen and a color-forming liquid composed of an oxidizing substance and a color-developing agent.
【0021】本発明に用いられるテトラアルキルベンジ
ジンは、置換アルキル基としては、メチル基、エチル
基、プロピル基が挙げられるが、メチル基が好ましい。
特に好ましいテトラアルキルベンジジンは、3,3′,5,
5′-テトラメチルベンジジンである。In the tetraalkylbenzidine used in the present invention, examples of the substituted alkyl group include a methyl group, an ethyl group and a propyl group, and a methyl group is preferable.
A particularly preferred tetraalkylbenzidine is 3,3 ′, 5,
It is 5'-tetramethylbenzidine.
【0022】本発明の測定法用組成物又は測定用キット
において、テトラアルキルベンジジンまたはその塩の濃
度は、0.01ないし5.0mg/mlであり、好ましくは0.05な
いし2.0mg/mlである。In the assay composition or assay kit of the present invention, the concentration of tetraalkylbenzidine or a salt thereof is 0.01 to 5.0 mg / ml, preferably 0.05 to 2.0 mg / ml.
【0023】本発明の測定法用組成物又は測定用キット
は緩衝剤を含有することが好ましく、緩衝剤としては、
クエン酸、酢酸、シュウ酸などの有機酸とクエン酸ナト
リウム、リン酸ナトリウムなどのナトリウム塩やカリウ
ム塩など有機酸塩または無機酸塩を選択することが出来
る。より好ましい緩衝剤としてはクエン酸が挙げられ
る。The composition for assay or the assay kit of the present invention preferably contains a buffering agent.
An organic acid such as citric acid, acetic acid or oxalic acid and an organic acid salt or an inorganic acid salt such as sodium salt or potassium salt such as sodium citrate or sodium phosphate can be selected. A more preferable buffering agent is citric acid.
【0024】また、発色を補助する成分として、キレー
ト剤(特開昭63-199270号)、非イオン性界面活性剤
(特開昭62-294099号)、トリポリりん酸(特開平1-243
998号)などを色原体を安定化させるために反応系に添
加することも出来る。As components for assisting color development, chelating agents (JP-A-63-199270), nonionic surfactants (JP-A-62-294099), tripolyphosphoric acid (JP-A-1-243)
No. 998) can be added to the reaction system to stabilize the chromogen.
【0025】本発明に係るペルオキシダーゼ様物質とし
ては、例えば、西洋ワサビペルオキシダーゼ、サイトク
ロムcペルオキシダーゼ、ラクトペルオキシダーゼ、ミ
エロペルオキシダーゼ、グルタチオンペルオキシダー
ゼ、また、鉄、金、銀などの金属及び金属化合物、ヘモ
グロビン等が挙げられるが、好ましくは西洋ワサビペル
オキシダーゼである。Examples of the peroxidase-like substance according to the present invention include horseradish peroxidase, cytochrome c peroxidase, lactoperoxidase, myeloperoxidase, glutathione peroxidase, and metals and metal compounds such as iron, gold and silver, hemoglobin and the like. However, horseradish peroxidase is preferable.
【0026】さらに、本発明で述べている酸化性物質と
は、ペルオキシダーゼの共存下で、テトラアルキルベン
ジジンを酸化することが可能なものであれば、どのよう
なものでも良い。具体的には、過酸化水素、アルキルヒ
ドロキシペルオキシド、p-ニトロペルオキシ安息香酸、
クメンヒドロキシペルオキシド、過酸化尿素等が挙げら
れるが、特に過酸化水素が好ましい。また、酸化性物質
の濃度は0.001ないし0.1%が好ましい。0.001%以下で
は感度が悪化し、0.1%以上では酵素活性が阻害され良
好な判定を行うことが不可能となるため再現性の点で好
ましくない。より好ましくは、0.005ないし0.02%であ
る。以上の条件を満たすものであれば、従来、同様の用
途に用いられてきた試薬と比較して、感度の面で優れた
結果が得られる。Further, the oxidizing substance described in the present invention may be any substance as long as it can oxidize tetraalkylbenzidine in the presence of peroxidase. Specifically, hydrogen peroxide, alkyl hydroxyperoxide, p-nitroperoxybenzoic acid,
Cumene hydroxyperoxide, urea peroxide and the like can be mentioned, but hydrogen peroxide is particularly preferable. The concentration of the oxidizing substance is preferably 0.001 to 0.1%. If it is 0.001% or less, the sensitivity is deteriorated, and if it is 0.1% or more, the enzyme activity is inhibited and a good judgment cannot be performed, which is not preferable in terms of reproducibility. More preferably, it is 0.005 to 0.02%. As long as the conditions described above are satisfied, excellent results can be obtained in terms of sensitivity as compared with reagents that have been conventionally used for similar purposes.
【0027】本発明をペルオキシダーゼを結合した抗体
もしくは抗原分子を用いた酵素免疫測定法に適合する場
合、EIA、ELISAなどにおいて通常行われている方法に準
じ、得られたペルオキシダーゼ活性を標準物質を用いる
ことにより得られたペルオキシダーゼ活性の検量線との
対比によって、検体中の測定対象物質の濃度(または
量、単位)を求めることが出来る。When the present invention is applicable to an enzyme immunoassay using an antibody or an antigen molecule to which a peroxidase is bound, the obtained peroxidase activity is used as a standard substance according to the method usually used in EIA, ELISA and the like. The concentration (or amount, unit) of the substance to be measured in the sample can be determined by comparing the thus obtained peroxidase activity with a calibration curve.
【0028】[0028]
【実施例】以下に実施例を示し本発明の詳細な説明を行
うが、これにより限定されるものではない。The present invention will be described in detail below with reference to examples, but the invention is not limited thereto.
【0029】実施例1 発色液の調製 酵素免疫測定法に用いるための測定法用組成物の調製を
行った。3,3′,5,5′-テトラアルキルベンジジンを2-メ
チルピペリジン(MePi)に溶解し、この溶液に表1に示し
た割合で0.1Mクエン酸-クエン酸ナトリウム緩衝液(pH
3.5)を加え撹拌した。これを発色液とした。同様に、Me
Piの代わりにジメチルスルフォキシド(DMSO)、N-メチル
-2-ピロリジノン(NMP)とジメチルスルフォキシドの1:1
混合物(NMP+DMSO)及び2-メチルピペリジンとモルホリ
ンの1:1混合物(MePi+Mo)にそれぞれ溶解し発色液を
作成した。Example 1 Preparation of Coloring Solution A composition for assay method for use in the enzyme immunoassay method was prepared. 3,3 ′, 5,5′-Tetraalkylbenzidine was dissolved in 2-methylpiperidine (MePi), and 0.1M citric acid-sodium citrate buffer solution (pH) was added to this solution at the ratio shown in Table 1.
3.5) was added and stirred. This was used as a color forming liquid. Similarly, Me
Dimethyl sulfoxide (DMSO), N-methyl instead of Pi
-2-Pyrrolidinone (NMP) and dimethyl sulfoxide 1: 1
The mixture was dissolved in a mixture (NMP + DMSO) and a 1: 1 mixture of 2-methylpiperidine and morpholine (MePi + Mo) to prepare a color developing solution.
【0030】[0030]
【表1】 [Table 1]
【0031】比較例として表2に示したように3,3′,5,
5′-テトラメチルベンジジン20mgをメタノール、エタノ
ール又はジメチルホルムアミド(DMF)にそれぞれ溶解
後、0.1Mクエン酸-クエン酸ナトリウム緩衝液(pH3.5)
と混合した発色液も作製した。As a comparative example, as shown in Table 2, 3,3 ′, 5,
Dissolve 5 mg of 5'-tetramethylbenzidine in methanol, ethanol or dimethylformamide (DMF), and then add 0.1M citric acid-sodium citrate buffer (pH 3.5).
A coloring solution mixed with was also prepared.
【0032】実施例2 ガラクトシルトランスフェラーゼ量の測定 実施例1で調製した、本発明の化合物を含有する3,3′,
5,5′-テトラメチルベンジジンの発色液と従来の方法で
調製された3,3′,5,5′-テトラメチルベンジジンを含有
する発色液を用いて、酵素免疫測定法の系により検討を
行った。Example 2 Determination of the amount of galactosyl transferase 3,3 ', containing the compound of the present invention prepared in Example 1
An enzyme immunoassay system was used to examine the color development solution of 5,5'-tetramethylbenzidine and the color development solution containing 3,3 ', 5,5'-tetramethylbenzidine prepared by the conventional method. went.
【0033】特開平3-259093号に記載されている抗癌関
連ガラクトシルトランスフェラーゼ(以下GATと略記)
モノクローナル抗体MAb8513を、1M塩化ナトリウム含有
0.1M炭酸緩衝液(pH9.15)中に10μg/mlに希釈し、こ
の溶液中にポリスチレン製ビーズ(積水化学製)を4℃
・24時間浸漬し抗体の固定化を行った。Anticancer-related galactosyltransferase (hereinafter abbreviated as GAT) described in Japanese Patent Laid-Open No. 3-259093
Monoclonal antibody MAb8513 containing 1M sodium chloride
Dilute to 10 μg / ml in 0.1 M carbonate buffer (pH 9.15) and add polystyrene beads (Sekisui Chemical Co., Ltd.) to this solution at 4 ° C.
・ Immersion was carried out for 24 hours to immobilize the antibody.
【0034】次に、ブロッキング溶液として牛血清アル
ブミン(以下BSAと略記)を1%含有する0.02Mリン酸緩
衝液(150mM NaCl含有pH7.3、以降PBSと称す)を調製
し、この溶液中に抗体固定化後のビーズを移し、37℃、
10時間浸漬・放置し、ビーズ表面の抗体非結合部位の被
覆(ブロッキング)を行った。これら一連の作業により
以下に用いる抗体固定化ビーズを得た。Next, a 0.02 M phosphate buffer solution (150 mM NaCl-containing pH 7.3, hereinafter referred to as PBS) containing 1% bovine serum albumin (hereinafter abbreviated as BSA) was prepared as a blocking solution, and this solution was prepared. Transfer the beads after antibody immobilization, 37 ℃,
After immersion for 10 hours and standing, coating (blocking) of antibody non-binding sites on the bead surface was performed. Through these series of operations, the antibody-immobilized beads used below were obtained.
【0035】検体としてGATを含有する癌患者プール血
清を用いた。この検体50μlに0.02Mリン酸緩衝液(pH
6.5、150mM NaCl及び0.01% Tween20含有)200μlを添
加し、ここに上記に記載の方法により調製した抗体固定
化ビーズを浸漬し、一次反応(45℃、2時間)を行っ
た。反応後PBSにて洗浄操作を行った。西洋ワサビペル
オキシダーゼ(以下 HRPと称す)にて標識したHRP標識抗G
AT抗体MAb8628(特開平3-259093号に記載)を1%BSA含
有PBS溶液に適宜希釈し、これを250μl添加し、二次反
応を行った。この後、同様にPBSによる洗浄操作を行っ
た。Cancer patient pool serum containing GAT was used as a sample. 50 μl of this sample was added with 0.02M phosphate buffer (pH
200 μl of 6.5, 150 mM NaCl and 0.01% Tween 20) was added, and the antibody-immobilized beads prepared by the method described above were immersed therein to carry out the primary reaction (45 ° C., 2 hours). After the reaction, washing operation was performed with PBS. HRP-labeled anti-G labeled with horseradish peroxidase (hereinafter referred to as HRP)
AT antibody MAb8628 (described in JP-A-3-259093) was appropriately diluted in a PBS solution containing 1% BSA, and 250 μl of this was added to carry out a secondary reaction. After that, a washing operation with PBS was similarly performed.
【0036】さらに、実施例1で調製した発色液をそれ
ぞれ300μl加え、室温にて30分発色反応を行った。ま
た、比較例として調製した発色液及び有機溶媒を含有し
ない発色液についても同様に反応を行った。反応後、そ
れぞれに1N H2SO4を1mlずつ添加し反応を停止させ、4
50nmでの吸光度を測定した。結果は、検量線の相関係数
によって比較した。これらの結果を図1及び表2に示
す。Further, 300 μl of each color-developing solution prepared in Example 1 was added, and a color-developing reaction was carried out at room temperature for 30 minutes. Further, the same reaction was performed for the color forming liquid prepared as a comparative example and the color forming liquid containing no organic solvent. After the reaction, add 1 ml of 1N H 2 SO 4 to each to stop the reaction.
Absorbance at 50 nm was measured. The results were compared by the correlation coefficient of the calibration curve. The results are shown in FIG. 1 and Table 2.
【0037】[0037]
【表2】 [Table 2]
【0038】その結果、本発明の3,3′,5,5′-テトラメ
チルベンジジンの発色液は、従来の3,3′,5,5′-テトラ
メチルベンジジンを用いた発色液と比較して、直線性に
優れるという結果が得られた。特に、本発明の化合物の
混合比は30〜60%の範囲において良好であるという結果
が得られた。また、複数の化合物が混在した場合の混合
比も化合物の合計量の比率が30〜60%の範囲の場合に良
好な結果が得られている。As a result, the color developing solution of 3,3 ', 5,5'-tetramethylbenzidine of the present invention was compared with the conventional color developing solution using 3,3', 5,5'-tetramethylbenzidine. As a result, excellent linearity was obtained. In particular, it was found that the mixing ratio of the compound of the present invention was good in the range of 30 to 60%. Also, as for the mixing ratio when a plurality of compounds are mixed, good results are obtained when the ratio of the total amount of the compounds is in the range of 30 to 60%.
【0039】実施例3 <発色液キットの製造>酵素免疫測定用キットに同包す
るための発色液キットの製造を行った。Example 3 <Production of color-developing solution kit> A color-developing solution kit to be included in the enzyme immunoassay kit was produced.
【0040】(1)発色剤の調製 クエン酸一水和物を3.95g秤量し、20ml程度の蒸留水を
加え溶解する。このクエン酸一水和物の溶液に3,3′,5,
5′-テトラメチルベンジジン50mgを加え撹拌して溶解さ
せる。溶解後蒸留水を加え全量を25mlに調整する。ここ
で得られた3,3′,5,5′-テトラメチルベンジジン溶液を
褐色のバイアル瓶に1mlずつ分注し、凍結乾燥を行う。
これを発色剤とした。(1) Preparation of color-developing agent 3.95 g of citric acid monohydrate is weighed, and about 20 ml of distilled water is added and dissolved. To this solution of citric acid monohydrate, 3,3 ', 5,
Add 50 mg of 5'-tetramethylbenzidine and stir to dissolve. After dissolution, add distilled water to adjust the total volume to 25 ml. The 3,3 ', 5,5'-tetramethylbenzidine solution thus obtained is dispensed into brown vials in an amount of 1 ml and freeze-dried.
This was used as a color former.
【0041】(2)基質溶液の調製 クエン酸三ナトリウム(二水和物)を9.18g秤量し、蒸
留水を250ml程度加え溶解する。この溶液にジメチルス
ルフォキシド及びN-メチル-2-ピロリジノンをそれぞれ1
00ml加え、さらに最終的に0.02重量%濃度になるように
過酸化水素水を加え良く撹拌した後、蒸留水を加え、全
量を500mlとする。この溶液を褐色のバイアル瓶に20ml
ずつ分注し、保存する。これを基質液とする。(2) Preparation of substrate solution 9.18 g of trisodium citrate (dihydrate) is weighed and dissolved in about 250 ml of distilled water. Dimethylsulfoxide and N-methyl-2-pyrrolidinone were added to this solution, respectively.
After adding 00 ml and further adding hydrogen peroxide solution to a final concentration of 0.02% by weight and stirring well, distilled water is added to bring the total amount to 500 ml. 20 ml of this solution in a brown vial
Dispense each one and save. This is the substrate solution.
【0042】(3)発色液の調製 (1)で製造した発色剤と(2)で調製した基質液を混合
し、発色液を調製した。この時、テトラメチルベンジジ
ンは完全に溶解し析出は認められなかった。(3) Preparation of color developing solution The color developing agent prepared in (1) and the substrate solution prepared in (2) were mixed to prepare a color developing solution. At this time, tetramethylbenzidine was completely dissolved and no precipitation was observed.
【0043】[0043]
【発明の効果】本発明により、固相に酵素標識抗体を固
定した酵素免疫測定法の系において検量線の直線性が飛
躍的に向上し、結果の再現性及び信頼性が飛躍的に向上
した。特に、ペルオキシダーゼを結合した抗体もしくは
抗原分子を用いた固相酵素免疫測定法において、テトラ
アルキルベンジジンまたはその塩を用いた場合顕著な効
果を示した。Industrial Applicability According to the present invention, the linearity of the calibration curve is dramatically improved in the enzyme immunoassay system in which the enzyme-labeled antibody is immobilized on the solid phase, and the reproducibility and reliability of the results are dramatically improved. . In particular, in a solid-phase enzyme immunoassay using a peroxidase-bound antibody or antigen molecule, a remarkable effect was obtained when tetraalkylbenzidine or a salt thereof was used.
【図1】本発明の酵素免疫測定法用組成物と従来の酵素
免疫測定法用組成物を用いた場合の抗原濃度と吸光度の
関係を示す図である。FIG. 1 is a diagram showing the relationship between the antigen concentration and the absorbance when the enzyme immunoassay composition of the present invention and a conventional enzyme immunoassay composition are used.
1 ジメチルスルフォキシドとN-メチル-2-ピロリジノ
ンの1:1混合物を40%の混合比で含む発色液を用いた
検量線(本発明) 2 ジメチルフォルムアミドを40%の混合比で含む発色
液を用いた検量線(比較例)1 Calibration curve using a coloring solution containing a 1: 1 mixture of dimethyl sulfoxide and N-methyl-2-pyrrolidinone at a mixing ratio of 40% (invention) 2 Coloring containing a mixture ratio of 40% dimethylformamide Calibration curve using liquid (comparative example)
Claims (7)
と酸化性物質を含有し、かつ、ジアルキルスルフォキシ
ド及び含窒素ヘテロ6員環化合物から選ばれる少なくと
も1種の化合物を30〜60%(v/v)の割合で含有すること
を特徴とする酵素免疫測定法用組成物。1. At least one compound containing tetraalkylbenzidine or a salt thereof and an oxidizing substance and selected from dialkyl sulfoxide and a nitrogen-containing hetero 6-membered ring compound is 30 to 60% (v / v). ) The composition for enzyme immunoassay, characterized in that the composition is contained.
と酸化性物質を含有し、かつ、下記一般式〔I〕で表さ
れる化合物の少なくとも2種を30〜60%(v/v)の割合で
含有することを特徴とする酵素免疫測定法用組成物。 【化1】 式中、Rは置換又は非置換のアルキル基を表す。2. A tetraalkylbenzidine or a salt thereof and an oxidizing substance, and at least 2 kinds of compounds represented by the following general formula [I] in a proportion of 30 to 60% (v / v). A composition for enzyme immunoassay characterized by comprising: Embedded image In the formula, R represents a substituted or unsubstituted alkyl group.
と酸化性物質を含有し、かつ、ジアルキルスルフォキシ
ド及び含窒素ヘテロ環化合物から選ばれる少なくとも1
種の化合物並びに上記一般式〔I〕で表される化合物か
ら選ばれる少なくとも1種の化合物を30〜60%(v/v)の
割合で含有することを特徴とする酵素免疫測定法用組成
物。3. At least one selected from a dialkyl sulfoxide and a nitrogen-containing heterocyclic compound, containing tetraalkylbenzidine or a salt thereof and an oxidizing substance.
Composition and at least one compound selected from the compounds represented by the above general formula [I] in an amount of 30 to 60% (v / v). .
を含有し、かつ、ジアルキルスルフォキシド及び含窒素
ヘテロ環化合物から選ばれる少なくとも1種の化合物を
反応液中に30〜60%(v/v)の割合で含有することを特徴
とする酵素免疫測定用キット。4. A reaction liquid containing at least one compound selected from the group consisting of dialkyl sulfoxide and nitrogen-containing heterocyclic compound containing tetraalkylbenzidine or a salt thereof in an amount of 30 to 60% (v / v). A kit for enzyme immunoassay, characterized in that it is contained in a ratio.
を含有し、かつ、上記一般式〔I〕で表される化合物か
ら選ばれる少なくとも2種の化合物を反応液中に30〜60
%(v/v)の割合で含有することを特徴とする酵素免疫測
定用キット。5. A reaction liquid containing at least two compounds containing tetraalkylbenzidine or a salt thereof and selected from the compounds represented by the above general formula [I] in an amount of 30 to 60.
% (V / v) is contained in the enzyme immunoassay kit.
を含有し、かつ、ジアルキルスルフォキシド及び含窒素
ヘテロ環化合物から選ばれる少なくとも1種の化合物並
びに上記一般式〔I〕で表される化合物から選ばれる少
なくとも1種の化合物を反応液中に30〜60%(v/v)の割
合で含有することを特徴とする酵素免疫測定用キット。6. A compound containing tetraalkylbenzidine or a salt thereof and selected from at least one compound selected from dialkyl sulfoxide and a nitrogen-containing heterocyclic compound and a compound represented by the above general formula [I]. A kit for enzyme immunoassay characterized in that at least one compound is contained in the reaction solution at a rate of 30 to 60% (v / v).
5′-テトラメチルベンジジンであることを特徴とする請
求項1、2、3、4、5又は6記載の酵素免疫測定法用
組成物色原体又は酵素免疫測定用キット。7. The tetraalkylbenzidine is 3,3 ′, 5,
The composition chromogen for enzyme immunoassay according to claim 1, 2, 3, 4, 5 or 6, which is 5'-tetramethylbenzidine, or the kit for enzyme immunoassay.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28529794A JPH08145997A (en) | 1994-11-18 | 1994-11-18 | Composition for method for measuring enzyme immunity and kit for measuring enzyme immunity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28529794A JPH08145997A (en) | 1994-11-18 | 1994-11-18 | Composition for method for measuring enzyme immunity and kit for measuring enzyme immunity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH08145997A true JPH08145997A (en) | 1996-06-07 |
Family
ID=17689706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP28529794A Pending JPH08145997A (en) | 1994-11-18 | 1994-11-18 | Composition for method for measuring enzyme immunity and kit for measuring enzyme immunity |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH08145997A (en) |
-
1994
- 1994-11-18 JP JP28529794A patent/JPH08145997A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2753598A1 (en) | Solution phase homogeneous assays | |
| CA3106473A1 (en) | Chemiluminescent substrates for peroxidase with extended shelf-life | |
| US6066505A (en) | Fluorescence polarization immunoassay | |
| EP0898620B1 (en) | Assay of peroxidase activity | |
| JPH08313525A (en) | Composition for measuring enzyme immunity and its preparation | |
| JPH0880199A (en) | Measurement of oxidizing substance, measurement of peroxidase-like substance, enzyme immunoassay or enzyme immunoassay dyeing and lyophilized composition to be used for these assays | |
| JPH07121235B2 (en) | Indicator and reagent kit for measuring peroxide-decomposable substances | |
| JP2960628B2 (en) | Immunoassay using labeled thyronine hapten analogs | |
| JP3711544B2 (en) | Chemiluminescence measuring reagent | |
| JPH08304396A (en) | Enzyme immunity measuring chromogen aqueous solution and enzyme immunity maeasuring kit | |
| JP2694004B2 (en) | Method for measuring fructosamine in serum or plasma | |
| JPH07198721A (en) | Buffer for immunoassay | |
| JPH0638757B2 (en) | Peroxidase or H ▲ lower 2 ▼ O ▲ lower 2 ▼ measuring method | |
| JPH07308200A (en) | Composition for detecting and measuring activity of peroxidase-like substance and detecting and measuring oxidizing substance and measuring method therefor | |
| JP2893139B2 (en) | Immunoturbidimetry and measuring reagents used for it | |
| JP2008164334A (en) | Enzyme immunoassay method and developing composition used therefor | |
| JP3632990B2 (en) | Chemiluminescence measuring reagent and chemiluminescence measuring method | |
| JP2535290B2 (en) | Indicator for measuring peroxide-decomposable substances | |
| JPH08220098A (en) | Enzyme immunity measuring method and enzyme immunity measuring reagent kit | |
| US20020192736A1 (en) | Assay of peroxidase activity | |
| JP3702545B2 (en) | Chemiluminescent reagent | |
| JP3685815B2 (en) | Method for stabilizing peroxidase in solution | |
| JPH05227995A (en) | Indicator and reagent kit for determination of peroxide-decomposing substance | |
| JP2885092B2 (en) | Method and reagent for measuring C-reactive protein | |
| JPH08288A (en) | Composition for determination of activity of peroxidase-like substance or detection and determination of oxidizing substance and determination method |